Formal negotiations between industry and the US Food and Drug Administration to reauthorize the generic drug and prescription drug user fees will begin this month, with talks for one program opening this week.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?